About Lumos Pharma (LUMO)
Lumos Pharma, Inc., formerly NewLink Genetics Corporation, is a clinical stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for rare diseases. Its lead product candidate is LUM-201, an ora... Read more
- USD2.65
- USD2.83
- USD2.53
- USD4.55
- -0.80%
- 2M
- 12.31k
- 10.93k
- 21M
- 2.41
- -19.60%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
